High tetracycline resistance percentages in Neisseria gonorrhoeae in Europe: is doxycycline post-exposure prophylaxis unlikely to reduce the incident gonorrhoea cases?

Collaborators, Affiliations

European Gonococcal Tetracycline-Resistance Study Group:
Eszter Balla, Beatrice Bercot, Maria José Borrego, Dominique Caugant, Michelle Cole, Brendan Crowley, Michaela Day, Irith De Baetselier, Dagmar Heuer, Susanne Jacobsson, Csaba Kodmon, Vivi Miriagou, Beata Młynarczyk-Bonikowska, Peter Pavlik, Ivva Philipova, Stefanie Schindler, Daniel Schröder, Raquel Abad Torreblanca, Kairi Tõnsau, Magnus Unemo, Alje Van Dam, Francesca Vella, Polona Maver Vodičar, Hana Zákoucká

¹ WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
² Institute for Global Health, University College London (UCL), London, UK.
³ UK Health Security Agency (UKHSA), London, UK.
⁴ European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Magnus Unemo et al. Lancet Reg Health Eur. 2024.

. 2024 Feb 13:38:100871.

doi: 10.1016/j.lanepe.2024.100871. eCollection 2024 Mar.

European Gonococcal Tetracycline-Resistance Study Group:
Eszter Balla, Beatrice Bercot, Maria José Borrego, Dominique Caugant, Michelle Cole, Brendan Crowley, Michaela Day, Irith De Baetselier, Dagmar Heuer, Susanne Jacobsson, Csaba Kodmon, Vivi Miriagou, Beata Młynarczyk-Bonikowska, Peter Pavlik, Ivva Philipova, Stefanie Schindler, Daniel Schröder, Raquel Abad Torreblanca, Kairi Tõnsau, Magnus Unemo, Alje Van Dam, Francesca Vella, Polona Maver Vodičar, Hana Zákoucká

¹ WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
² Institute for Global Health, University College London (UCL), London, UK.
³ UK Health Security Agency (UKHSA), London, UK.
⁴ European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

No abstract available

Conflict of interest statement

We declare no competing interest.

1. Luetkemeyer A.F., Donnell D., Dombrowski J.C., et al. Postexposure doxycycline to prevent bacterial sexually transmitted infections. N Engl J Med. 2023;388:1296–1306. - PMC - PubMed
1. Molina J.M., Charreau I., Chidiac C., et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018;18:308–317. - PubMed
1. Mårdh O., Plachouras D. Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic Area. Euro Surveill. 2023;28 - PMC - PubMed
1. Kakooza F., Golparian D., Matoga M., et al. Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20. J Antimicrob Chemother. 2023;78:1982–1991. - PubMed
1. Harrison W.O., Hooper R.R., Wiesner P.J., et al. A trial of minocycline given after exposure to prevent gonorrhea. N Engl J Med. 1979;300:1074–1078. - PubMed